In one meta-analysis by Singal et al., a single nucleotide polymorphism—PNPLA3—was associated with increased risk of fibrosis (OR 1.23) and HCC (OR 1.67) in patients with NAFLD [135]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.